FDA recall

Manufacturing

Takeda hit with CRL, extending struggles for Natpara

Takeda’s long slog to manufacture its rare disease med Natpara got a lot tougher with a CRL from the FDA.
Joseph Keenan Mar 22, 2022 10:18am

Sun and Lupin pulled clonazepam and lisinopril lots in the U.S.

Aug 10, 2020 11:30am

Zantac, generics ordered off the market by FDA for cancer risk

Apr 1, 2020 12:05pm

Nearly half of FDA warning letters knock Indian, Chinese plants: report

Aug 29, 2019 8:30am

Pentagon eyeing Chinese production of tainted 'sartan' API

Aug 6, 2019 9:43am

Tainted blood pressure drugs continue to show up in U.S. supply

Jun 13, 2019 9:35am